Amyloid β
Amyloid β denotes peptides of 36–43 amino acids result from the APP (amyloid precursor protein) and are involved in Alzheimer's disease as the main component of the amyloid plaques.
Products Related to Amyloid β(118)
- GC68725BapineuzumabCAS: 648895-38-9Purity: >96.00%
Bapineuzumab is a monoclonal antibody that targets beta-amyloid protein (APP). It can be used in the research of Alzheimer's disease (AD).
- GC68996DonanemabCAS: 1931944-80-7Purity: >97.00%
Donanemab is a humanized IgG1 monoclonal antibody. Donanemab targets deposited Aβ42, and clear amyloid plaques in the brain through microglia-mediated phagocytosis. Donanemab mainly localized in the plasma and extracellular space and penetrates the brain across the blood–brain barrier to bind Aβ deposits. Donanemab is an effective treatment for Alzheimer's disease.
- GC69150GantenerumabCAS: 1043556-46-2Purity: 98.50%
Gantenerumab is a fully human monoclonal antibody against amyloid-beta (Aβ) of the IgG1 class, which shows sustained binding to brain amyloid-beta. Gantenerumab can be used for Alzheimer's disease research.
- GC70182β-Amyloid (1-40), FAM-labeled TFAPurity: >99.00%
Beta-amyloid (1-40), FAM-labeled TFA is a FAM fluorescently labeled beta-amyloid (1-40) peptide (Λex= 492 nm and Λem= 518 nm).
- GN10307Ginsenoside ReCAS: 52286-59-6Purity: >99.00%
Ginsenoside Re is a natural compound found in Panax ginseng , possessing potent antioxidant and anti-inflammatory bioactivities.
- GN10544Ginsenoside Rg1CAS: 22427-39-0Purity: >98.00%
Ginsenoside Rg1, one of the main active components found in Panax ginseng, is a class of natural products known as steroid glycosides with a wide range of biological activities.
- GN10695Notoginsenoside R1CAS: 80418-24-2Purity: >98.00%
Notoginsenoside R1 is a major active saponin component isolated from Panax notoginseng and is a key bioactive compound in many traditional Chinese medicine formulations.
- GN1079920(S)-Ginsenoside Rg3CAS: 14197-60-5Purity: >98.00%
20(S)-Ginsenoside Rg3 is a rare ginsenoside extracted from ginseng (Na + : IC 50 = 32.2±4.5μM; hKv1.4: IC 50 = 32.6±2.2μM).
- GP10049Amyloid Beta-Peptide (12-28) (human)CAS: 107015-83-8Purity: >95.00%
Amyloid Beta-Peptide (12-28) (human) is a peptide fragment of amyloid beta protein (1-42) (Aβ (1-42)).
- GP10082Amyloid Beta-peptide (25-35) (human)CAS: 131602-53-4Purity: >98.50%
Amyloid beta(Aβ)-peptide (25-35) (human) is an fragment of Alzheimer's Amyloid beta peptide which is commonly found in the brains of people with Alzheimer's disease (AD) and is a major component of Alzheimer's amyloid plaques.
- GP10099amyloid A protein fragment [Homo sapiens]Purity: >98%
Apolipoproteins related to HDL in plasma
- GP10118Amyloid Beta-Peptide (1-40) (human)CAS: 131438-79-4Purity: >96.00%
Amyloid Beta-Peptide (1-40) (human) is the main component of senile plaque amyloid and is a physiological peptide present in the brain, cerebrospinal fluid (CSF), and plasma.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC68725 | Bapineuzumab | 648895-38-9 | >96.00% | |
Bapineuzumab is a monoclonal antibody that targets beta-amyloid protein (APP). It can be used in the research of Alzheimer's disease (AD). | ||||
| GC68996 | Donanemab | 1931944-80-7 | >97.00% | |
Donanemab is a humanized IgG1 monoclonal antibody. Donanemab targets deposited Aβ42, and clear amyloid plaques in the brain through microglia-mediated phagocytosis. Donanemab mainly localized in the plasma and extracellular space and penetrates the brain across the blood–brain barrier to bind Aβ deposits. Donanemab is an effective treatment for Alzheimer's disease. | ||||
| GC69150 | Gantenerumab | 1043556-46-2 | 98.50% | |
Gantenerumab is a fully human monoclonal antibody against amyloid-beta (Aβ) of the IgG1 class, which shows sustained binding to brain amyloid-beta. Gantenerumab can be used for Alzheimer's disease research. | ||||
| GC70182 | β-Amyloid (1-40), FAM-labeled TFA | - | >99.00% | |
Beta-amyloid (1-40), FAM-labeled TFA is a FAM fluorescently labeled beta-amyloid (1-40) peptide (Λex= 492 nm and Λem= 518 nm). | ||||
| GN10307 | Ginsenoside Re | 52286-59-6 | >99.00% | |
Ginsenoside Re is a natural compound found in Panax ginseng , possessing potent antioxidant and anti-inflammatory bioactivities. | ||||
| GN10313 | Schisantherin B | 58546-55-7 | >99.50% | |
| GN10428 | Geniposide | 24512-63-8 | >99.50% | |
| GN10502 | Saikosaponin C | 20736-08-7 | >98.00% | |
| GN10544 | Ginsenoside Rg1 | 22427-39-0 | >98.00% | |
Ginsenoside Rg1, one of the main active components found in Panax ginseng, is a class of natural products known as steroid glycosides with a wide range of biological activities. | ||||
| GN10614 | Ginsenoside Rg2 | 52286-74-5 | >98.00% | |
| GN10695 | Notoginsenoside R1 | 80418-24-2 | >98.00% | |
Notoginsenoside R1 is a major active saponin component isolated from Panax notoginseng and is a key bioactive compound in many traditional Chinese medicine formulations. | ||||
| GN10799 | 20(S)-Ginsenoside Rg3 | 14197-60-5 | >98.00% | |
20(S)-Ginsenoside Rg3 is a rare ginsenoside extracted from ginseng (Na + : IC 50 = 32.2±4.5μM; hKv1.4: IC 50 = 32.6±2.2μM). | ||||
| GP10046 | Amyloid Precursor C-Terminal Peptide | - | >98% | |
For beta amyloid generation | ||||
| GP10049 | Amyloid Beta-Peptide (12-28) (human) | 107015-83-8 | >95.00% | |
Amyloid Beta-Peptide (12-28) (human) is a peptide fragment of amyloid beta protein (1-42) (Aβ (1-42)). | ||||
| GP10057 | Amyloid β-Peptide (10-20) (human) | 152286-31-2 | >98% | |
| GP10082 | Amyloid Beta-peptide (25-35) (human) | 131602-53-4 | >98.50% | |
Amyloid beta(Aβ)-peptide (25-35) (human) is an fragment of Alzheimer's Amyloid beta peptide which is commonly found in the brains of people with Alzheimer's disease (AD) and is a major component of Alzheimer's amyloid plaques. | ||||
| GP10083 | Beta-Amyloid (1-11) | 190436-05-6 | >98% | |
| GP10094 | Amyloid β-peptide (10-35), amide | - | >98% | |
| GP10097 | Amyloid β-Protein (1-15) | 183745-81-5 | >98% | |
| GP10099 | amyloid A protein fragment [Homo sapiens] | - | >98% | |
Apolipoproteins related to HDL in plasma | ||||
| GP10118 | Amyloid Beta-Peptide (1-40) (human) | 131438-79-4 | >96.00% | |
Amyloid Beta-Peptide (1-40) (human) is the main component of senile plaque amyloid and is a physiological peptide present in the brain, cerebrospinal fluid (CSF), and plasma. | ||||
| GC10660 | EHT 1864 | 754240-09-0 | >98.00% | |
Rac family small GTPases inhibitor | ||||
